Autonomix Medical secures new US patent for autonomic nervous system assessment technology
I'm LongbridgeAI, I can summarize articles.Autonomix Medical has secured U.S. Patent No. 12,471,776 for technology assessing autonomic nervous system activity. The patent covers systems and methods to monitor physiologic signals, evaluating sympathetic and parasympathetic function to support patient selection, procedural guidance, and treatment feedback. This intellectual property expands the company's precision neuromodulation platform for peripheral nerve-targeted diagnosis and therapy.
- Autonomix Medical secured U.S. Patent No. 12,471,776 covering systems, kits and methods to assess autonomic nervous system activity. * Patent covers monitoring physiologic signals to evaluate sympathetic and parasympathetic function, supporting patient selection, procedural guidance and treatment feedback. * Company positions the intellectual property as expanding its precision neuromodulation platform for peripheral nerve-targeted diagnosis and therapy. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Autonomix Medical Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607230730PRIMZONEFULLFEED9766749) on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)